MétaCan
Menu
Back to cohort
Record W2538736652 · doi:10.1016/j.jalz.2016.06.1494

P2‐124: Brain Isoprenoids and Alzheimer's Disease

2016· article· en· W2538736652 on OpenAlexaffabout
Sandra Pelleïeux, Youla S. Tsantrizos, Louise Théroux, Doris Dea, Judes Poirier

Bibliographic record

VenueAlzheimer s & Dementia · 2016
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicPlant biochemistry and biosynthesis
Canadian institutionsMcGill UniversityDouglas Mental Health University Institute
Fundersnot available
KeywordsMevalonate pathwayFarnesyl pyrophosphateGeranylgeranyl pyrophosphateRHOAPrenylationCDC42TerpenoidChemistryAlzheimer's diseaseGTPaseBiologyBiochemistryCell biologyInternal medicineSignal transductionDiseaseMedicineATP synthaseEnzymeBiosynthesis

Abstract

fetched live from OpenAlex

The mevalonate pathway has been described to play a key role in Alzheimer's disease (AD). Farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) are non-sterol isoprenoid intermediates from mevalonate. They lead to protein prenylation which plays a crucial role in controlling cell signalling and proliferation. hFPP and hGGPP synthases lead to prenylation of small GTPase protein RhoA-cdc42, that have been shown to be associated with the accumulation of phospho-tau protein in the brain. It is hypothesise that these intermediates are implicated in tau dysregulation and the progression of AD. A better understanding of the role of hFPPs and hGGPPs in the pathophysiology of Alzheimer's disease may prove to be essential to assess the function of the isoprenoids pathway as a potential target in prevention of AD. In the first part of this work, we measured cortical mRNA levels of hFPPs and hGGPPs (RT-qPCR) and, GGPP and FPP concentrations by Liquid chromatography-tandem mass spectrometry (LC/MS/MS) in control and AD brain tissues obtained from the Douglas-Bell Brain Bank (Montréal, Canada). In the second part, hFPPs and hGGPPs inhibitors derived from the nitrogen-containing bisphosphonates (N-BP) were tested on human SH-SY5Y neurons and their effect on the accumulation of tau and Phospho-tau was measured as a function of time and concentrations. In autopsied frontal cortex, we found a significant positive correlation between mRNA levels (p<0.001, n=124), FFP and GGPP (p<0.05, n=116) and disease status. The levels of mRNA for hFFPs and hGGPPs also correlated with the amount of phospho-tau protein levels (p<0.05, n=38) and neurofibrillary tangles density (p<0.006, n=40) in frontal cortex. We also found that high levels of hFPPS and hGGPPS mRNA prevalence is significantly associated with earlier age of onset in AD (p<0.05, n=64). Finally, preliminary data indicates that our novel families of inhibitors can decrease phospho-tau levels in SH-SY5Y neurons without any detectable toxicity. Together, these results suggest that accumulation of phospho-tau in the AD brain is related to increase levels of neuronal isoprenoids; a phenomenon that could be alleviated by the administration of specific and potent bi-phosphonate derivatives. supported by the J.L. Lévesques Foundation, Canadian Institute of Health Research and FQRNT.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.233
Teacher spread0.220 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes2
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicPlant biochemistry and biosynthesisFrench-language works237,207